Skip to content

Aspiration based thrombectomy in acute large artery occlusive stroke with dIfferent etiologies: A real-world multicenter study

Aspiration based thrombectomy in acute large artery occlusive stroke with dIfferent etiologies: A real-world multicenter study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200065172
Enrollment
Unknown
Registered
2022-10-30
Start date
2022-11-10
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic stroke

Interventions

Posterior circulation group:Endovascular thrombectomy
Anterior circulation group:Endovascular thrombectomy

Sponsors

Shandong Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1)Patients with acute ischemic stroke; 2)Aged = 18 years; 3)mRS 0–1 before the onset; 4)occlusion site at ICA, M1, M2, VA or BA on CT angiography or MR angiography 5)ASPECTS =3 on CT or DWI of MRI; 6)Within 6 hours of onset or 6-24 hours after onset with indication for endovascular treatment according to multimode imaging evaluation.

Exclusion criteria

Exclusion criteria: 1)Evidence of acute intracranial hemorrhage on CT or MRI; 2)Clinically confirmed or suspected chronic occlusion or dissection with the responsible vessel; 3)Women with pragnancy or in lactation period; 4)Known allergy (more severe than skin rash) to contrast agents; 5)High risk of hemorrhage (platelet 50 second or PT-INR > 3.0), history of coagulation disorder, systemic haemorrhage, thrombocytopenia or neutropenia; 6)Patients with serious or fatal comorbidities (liver and kidney dysfunction, cardiopulmonary dysfunction, life expectancy less than 3 months, etc.) for whom the investigator judged that intravascular therapy was not appropriate; 7)Patients who in the judgment of the investigator, are likely to be non-compliant or uncooperative during the study due to various reasons such as mental illness, cognitive or emotional disorders, etc. 8)Significant mass effect with midline shift on CT or MRI.

Design outcomes

Primary

MeasureTime frame
Achievement of mRS 0–3 at 90 days;Successful recanalization confirmed by DSA(TICI 2b/3 grade);

Secondary

MeasureTime frame
Achievement of mRS 0–2 at 90 days;Achievement of mRS 0–1 at 90 days;One scale shift of mRS (shift analysis);NIHSS improvement of = 8 points at 48 hours;NIHSS at 90 days;ED-5Q at 90 days;Achievement of TICI 2b-3;Achievement of TICI 2b-3 after the first pass;Mean procedure time;Mean number of passes;Mean time from puncture to recanalization;

Countries

China

Contacts

Public ContactQinjian Sun

Shandong Provincial Hospital

sqj1210@163.com8615168885366

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026